For Fitzpatrick III-V skin, the anti-inflammatory mechanism of GHK-Cu is an active clinical advantage, reducing the inflammatory response that can lead to post-inflammatory hyperpigmentation in darker skin tones
There are no shortcuts
In some embodiments, the otic formulation or composition comprises about 0.01% by weight of the therapeutic agent, or pharmaceutically acceptable prodrug or salt thereof
L-NAME initially caused all vessels to disappear more rapidly and L-arginine increased the number of vessels (L-NAME R, L-arginine R, opposite ), but both induced larger pale areas (L-NAME R, L-arginine R, parallel ), all as NO-specific (NO-related) effects, as L-NAME and L-arginine regularly attenuated or antagonized each others responses (L-NAME R, L-arginine R, opposite , specific